Curran Brugger has been VP Talent, Development & Inclusion at Gilead Sciences since 2020. In this role, she leads Gilead’s talent and culture strategies aligned with the business transformation efforts. Prior to this, she worked for almost two decades in various executive HR and talent positions in leading pharmaceutical companies such as Novartis, Bristol-Myers Squibb, and AstraZeneca.

Gilead Sciences, Inc. is a research-based biopharmaceutical company, which discovers, develops and commercializes innovative medicines in areas of unmet medical need. The firm’s primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. The company was founded in 1987 and is headquartered in Foster, CA. With each new discovery and investigational drug candidate the company with its 18,000 employees seeks to improve the care of patients living with life-threatening diseases around the world.